Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy

Por Tsuji, Takemasa, Gnjatic, Sacha
Publicado em 2012

TLR AGONISTS: Are They Good Adjuvants?

Por Bhardwaj, Nina, Gnjatic, Sacha, Sawhney, Nikhil B.
Publicado em 2010

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs

Por Alabanza, Leah, Gnjatic, Sacha, Bhardwaj, Nina, Brody, Joshua
Publicado em 2014

Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity

Por Germain, Claire, Gnjatic, Sacha, Dieu-Nosjean, Marie-Caroline
Publicado no Front Immunol (2015)

The abscopal effect associated with a systemic anti-melanoma immune response

Por Stamell, Emily F., Wolchok, Jedd D., Gnjatic, Sacha, Lee, Nancy Y., Brownell, Isaac
Publicado em 2012

Inducing Efficient Cross-priming Using Antigen-coated Yeast Particles

Por Howland, Shanshan W., Tsuji, Takemasa, Gnjatic, Sacha, Ritter, Gerd, Old, Lloyd J., Wittrup, Karl Dane
Publicado em 2008

Non-classical antigen processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells

Por Matsuzaki, Junko, Tsuji, Takemasa, Luescher, Immanuel, Old, Lloyd J., Shrikant, Protul, Gnjatic, Sacha, Odunsi, Kunle
Publicado em 2013

HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer

Por Szender, J. Brian, Eng, Kevin H., Matsuzaki, Junko, Miliotto, Anthony, Gnjatic, Sacha, Tsuji, Takemasa, Odunsi, Kunle
Publicado no Gynecol Oncol (2016)

Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4(+) but Not CD8(+) T Cell Responses against p53 in Cancer Patients and Healthy Donors

Por Tsuji, Takemasa, Matsuzaki, Junko, Ritter, Erika, Miliotto, Anthony, Ritter, Gerd, Odunsi, Kunle, Old, Lloyd J., Gnjatic, Sacha
Publicado em 2011

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

Por Nagata, Yasuhiro, Ono, Satoru, Matsuo, Mitsutoshi, Gnjatic, Sacha, Valmori, Danila, Ritter, Gerd, Garrett, Wendy, Old, Lloyd J., Mellman, Ira
Publicado em 2002

Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy

Por Matsuzaki, Junko, Tsuji, Takemasa, Luescher, Immanuel, Shiku, Hiroshi, Mineno, Junichi, Okamoto, Sachiko, Old, Lloyd, Shrikant, Protul, Gnjatic, Sacha, Odunsi, Kunle
Publicado no J Immunother Cancer (2015)

IFN-γ enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

Por Matsuo, Mitsutoshi, Nagata, Yasuhiro, Sato, Eiichi, Atanackovic, Djordje, Valmori, Danila, Chen, Yao-Tseng, Ritter, Gerd, Mellman, Ira, Old, Lloyd J., Gnjatic, Sacha
Publicado em 2004

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses

Por Matsuzaki, Junko, Tsuji, Takemasa, Luescher, Immanuel F., Shiku, Hiroshi, Mineno, Junichi, Okamoto, Sachiko, Old, Lloyd J., Shrikant, Protul, Gnjatic, Sacha, Odunsi, Kunle
Publicado no Sci Rep (2015)

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas

Por Chen, Yao-Tseng, Chadburn, Amy, Lee, Peishan, Hsu, Melinda, Ritter, Erika, Chiu, April, Gnjatic, Sacha, Pfreundschuh, Michael, Knowles, Daniel M., Old, Lloyd J.
Publicado em 2010

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4(+)T Lymphocytes of Patients with Ny-Eso-1–Expressing Me...

Por Jäger, Elke, Jäger, Dirk, Karbach, Julia, Chen, Yao-Tseng, Ritter, Gerd, Nagata, Yasuhiro, Gnjatic, Sacha, Stockert, Elisabeth, Arand, Michael, Old, Lloyd J., Knuth, Alexander
Publicado em 2000

Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming

Por Atanackovic, Djordje, Altorki, Nasser K., Cao, Yanran, Ritter, Erika, Ferrara, Cathy A., Ritter, Gerd, Hoffman, Eric W., Bokemeyer, Carsten, Old, Lloyd J., Gnjatic, Sacha
Publicado em 2008

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy

Por de Carvalho, Fabricio, Vettore, Andre L., Inaoka, Riguel J., Karia, Bruno, Andrade, Valéria C. C., Gnjatic, Sacha, Jungbluth, Achim A., Colleoni, Gisele W. B.
Publicado em 2011

Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

Por Hunder, Naomi N., Wallen, Herschel, Cao, Jianhong, Hendricks, Deborah W., Reilly, John Z., Rodmyre, Rebecca, Jungbluth, Achim, Gnjatic, Sacha, Thompson, John A., Yee, Cassian
Publicado em 2008

Enhancement of tumor-reactive cytotoxic CD4(+) T cell responses after ipilimumab treatment in four advanced melanoma patients

Por Kitano, Shigehisa, Tsuji, Takemasa, Liu, Caillian, Hirschhorn-Cymerman, Daniel, Kyi, Chrisann, Mu, Zhenyu, Allison, James P., Gnjatic, Sacha, Yuan, Jianda D., Wolchok, Jedd D.
Publicado em 2013

A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence

Por Judge, Joshua M., Brill, Louis B., Smith, Kelly T., Deacon, Donna H., Patterson, James W., Grosh, William W., Jungbluth, Achim A., Gnjatic, Sacha, Slingluff, Craig L.
Publicado em 2013